Creative Biogene has long-term devoted to the development of vaccine technology. We offer multiple vaccine production services, using genetic engineering techniques to introduce specific antigens into microbial cells. These vaccines offer advantages such as safety, scalability, and the ability to target multiple diseases. Microbial systems, particularly bacteria (e.g., E. coli) and yeast (e.g., S. cerevisiae), are widely used for the production of recombinant vaccines. They are the most thoroughly studied and best-understood organisms because of the wealth of information on their genetics, biochemistry, and physiology. Furthermore, they are easy to culture in large amounts in economical media and multiply very rapidly. These features make them a versatile and cost-effective platform.
- Current Events
- Upcoming Events
- Past Events